728 results on '"Kanwar, Manreet"'
Search Results
152. EKG PARAMETERS IN PREDICTING SURVIVALS IN PULMONARY ARTERIAL HYPERTENSION
153. Role of Phosphodiesterase-5 Inhibitors in Heart Failure: Emerging Data and Concepts
154. Impact of Age on Outcomes in Patients With Cardiogenic Shock
155. Phenotyping Cardiogenic Shock
156. Development and validation of a claims-based model to identify patients at risk of chronic thromboembolic pulmonary hypertension following acute pulmonary embolism
157. ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part II: Cardiac, surgical, perioperative, operative, and post-operative challenges and management statements
158. Phenotyping cardiogenic shock
159. Macitentan (Opsumit) for the treatment of pulmonary arterial hypertension
160. Machine learning, artificial intelligence and mechanical circulatory support: A primer for clinicians
161. Clinical Outcomes Associated With Acute Mechanical Circulatory Support Utilization in Heart Failure Related Cardiogenic Shock
162. Elevated Pulmonary Pressure Noted on Echocardiogram: A Simplified Approach to Next Steps
163. Right Ventricular Pressure-Volume Analysis During a Left Ventricular Assist Device Speed Optimization Study
164. Reply
165. Congestion in AMI-Cardiogenic Shock: Rethinking Treatment Goals.
166. Misdiagnosis of Community-Acquired Pneumonia and Inappropriate Utilization of Antibiotics: Side Effects of the 4-h Antibiotic Administration Rule
167. Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials
168. Management of Patients With Venous Thromboembolism After the Initial Treatment Period
169. Outcomes of patients hospitalized for acute pulmonary embolism by obstructive sleep apnea status
170. Management of Pulmonary Hypertension due to Heart Failure with Preserved Ejection Fraction
171. TCT CONNECT-177 Impact of Age on Outcomes in Cardiogenic Shock: Analysis of the Cardiogenic Shock Working Group (CSWG)
172. CLINICAL IMPACT OF LIQ861 THROUGH ASSESSMENT BY THE CARDIOMEMS SYSTEM IN PULMONARY ARTERIAL HYPERTENSION: A CASE STUDY
173. TCT CONNECT-171 Compatibility of Novel Cardiogenic Shock Phenotypes From the Cardiogenic Shock Working Group (CSWG) With the SCAI Staging System
174. Longterm Survival on LVAD Support: Limitations Driven by Development of Device Complications and End-Organ Dysfunction
175. Data on clinical and economic burden associated with pulmonary arterial hypertension related hospitalizations in the United States
176. Impact of transcatheter aortic valve replacement on left ventricular hypertrophy, diastolic dysfunction and quality of life in patients with preserved left ventricular function
177. Sequential Pattern Mining of Longitudinal Adverse Events After Left Ventricular Assist Device Implant
178. Sex-related Differences in Heart Disease: Another Piece of the Puzzle
179. Risk stratification in pulmonary arterial hypertension using Bayesian analysis
180. Bionic women and men ‐ Part 2: Arterial stiffness in heart failure patients implanted with left ventricular assist devices
181. Bionic women and men ‐ Part 1: Cardiovascular lessons from heart failure patients implanted with left ventricular assist devices
182. Biomarkers in pulmonary arterial hypertension: Moving closer toward precision medicine?
183. Bionic women and men ‐ Part 4: Cardiovascular, cerebrovascular and exercise responses among patients supported with left ventricular assist devices
184. Bionic women and men ‐ Part 3: Right ventricular dysfunction in patients implanted with left ventricular assist devices
185. PREDICTING CARDIAC STRUCTURAL AND FUNCTIONAL IMPROVEMENT INDUCED BY MECHANICAL UNLOADING IN CHRONIC HEART FAILURE: A DERIVATION-VALIDATION MULTICENTER STUDY
186. CONTEMPORARY TRENDS IN LEFT VENTRICULAR ASSIST DEVICE IMPLANTATIONS AND ASSOCIATED OUTCOMES IN CANCER PATIENTS FROM 2008 THROUGH 2016: INSIGHTS FROM NATIONAL INPATIENT SAMPLE
187. Switching to riociguat: a potential treatment strategy for the management of CTEPH and PAH
188. Pediatric and Neonatal Patients Are Particularly Vulnerable to Epinephrine Dosing Errors
189. Confusion About Epinephrine Dosing Leading to Iatrogenic Overdose: A Life-Threatening Problem With a Potential Solution
190. Response
191. Right Ventricular Dysfunction Is Common and Identifies Patients at Risk of Dying in Cardiogenic Shock.
192. Role of medical management of cardiogenic shock in the era of mechanical circulatory support
193. Right Ventricular Pressure-Volume Analysis During Left Ventricular Assist Device Speed Optimization Studies: Insights Into Interventricular Interactions and Right Ventricular Failure.
194. Monitoring Pulmonary Arterial Hypertension Using an Implantable Hemodynamic Sensor
195. HEMODYNAMIC PARAMETERS IN PREDICTING SURVIVAL IN PULMONARY ARTERIAL HYPERTENSION
196. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study
197. A Comparative Analysis of Clinical Variables Associated with Hospitalization in Pulmonary Arterial Hypertension
198. Implementation and Outcomes of a Pulmonary Embolism Response Team: A Single Center Experience
199. Bridging the Gap to LVAD Recovery and Explantation
200. Factors Affecting Health Care Engagement of Patients With End-Stage Heart Failure: An Exploratory Survey Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.